Nutcracker Therapeutics
Latest round
- Series C
Last raised
- Aug 2021
Total raised
- $159M
Investors
- 2
About Nutcracker Therapeutics
Nutcracker Therapeutics, Inc.Founded in 2018 in Emeryville, US, Nutcracker Therapeutics specializes in RNA therapeutics. Igor Khandros, one of the co-founders, currently serves as CEO.Nutcracker Therapeutics specializes in advanced RNA therapeutics through a proprietary end-to-end platform that combines RNA design, nanoparticle delivery, and GMP biochip-based manufacturing. Their core offerings focus on accelerating the development and production of RNA-based treatments for complex diseases.Nutcracker Therapeutics generates revenue primarily through partnerships and collaborations with clinical institutions and other stakeholders in the healthcare sector.50 mn in August 2021, Nutcracker Therapeutics plans to enhance its pipeline of mRNA medicines for cancer. The company is also targeting expansion into new markets and geographic regions, although specific regions and timelines have not been disclosed.
Who invested in Nutcracker Therapeutics
2 investors across 2 rounds
See all investors in Nutcracker Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Nutcracker Therapeutics
Who invested in Nutcracker Therapeutics?
Nutcracker Therapeutics has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Nutcracker Therapeutics raised?
Nutcracker Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Nutcracker Therapeutics last raise money?
Nutcracker Therapeutics's most recent round on record is a Series C, in Aug 2021.
What does Nutcracker Therapeutics do?
Nutcracker Therapeutics is a biotechnology company.
Where is Nutcracker Therapeutics headquartered?
Nutcracker Therapeutics is headquartered in Emeryville, US.
Which VCs invest in companies like Nutcracker Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Nutcracker Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Nutcracker Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.